Production (Stage)
Ikena Oncology, Inc.
IKNA
$1.43
$0.064.38%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 53.91% | 40.50% | 27.77% | 5.06% | -6.28% |
| Total Depreciation and Amortization | -58.86% | -64.48% | -51.96% | -23.68% | -4.24% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -52.27% | -50.13% | -25.94% | 23.68% | 27.08% |
| Change in Net Operating Assets | 78.99% | 89.77% | 81.64% | 43.85% | 11.01% |
| Cash from Operations | 59.82% | 51.11% | 42.31% | 18.54% | 0.25% |
| Capital Expenditure | -- | -- | -- | 31.59% | 82.69% |
| Sale of Property, Plant, and Equipment | -21.16% | 525.00% | -- | 10,675.00% | 5,925.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 470.31% | -19.01% | -154.74% | -127.74% | -87.48% |
| Cash from Investing | 474.47% | -16.96% | -154.41% | -127.62% | -87.19% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | 100.00% | 83.71% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -99.85% | -- |
| Cash from Financing | -- | -- | -- | -99.92% | 5.27% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 151.98% | -168.93% | -233.99% | -240.07% | -217.04% |